Sign In
Buy EXEL
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026
Why Is Exelixis (EXEL) Down 8.8% Since Last Earnings Report?
12:47pm, Thursday, 08'th Sep 2022
Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock?
Nasdaq Bear Market: 5 Exceptional Growth Stocks You'll Regret Not Buying On the Dip
05:21am, Saturday, 20'th Aug 2022
These stand-out growth stocks are ripe for the picking following a peak decline of 34% in the Nasdaq Composite.
2 No-Brainer Bio-Tech Stocks to Buy Right Now
10:23am, Saturday, 13'th Aug 2022
These two drug makers have outshined the market this year.
Exelixis (EXEL) Q2 Earnings Beat, Cabometyx Maintains Growth
02:18pm, Wednesday, 10'th Aug 2022
Exelixis (EXEL) tops earnings and sales in the second quarter as lead drug Cabometyx maintains momentum.
Exelixis (EXEL) Beats Q2 Earnings and Revenue Estimates
07:33pm, Tuesday, 09'th Aug 2022
Exelixis (EXEL) delivered earnings and revenue surprises of 10% and 7.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Exelixis Handily Beats Second-Quarter Expectations, Retains 2022 Outlook
04:14pm, Tuesday, 09'th Aug 2022
Exelixis easily beat second-quarter expectations and retained its full-year outlook on Tuesday. But EXEL stock was unmoved.
2 Top Biotech Stocks Defying the Bear Market
10:23am, Saturday, 06'th Aug 2022
These drugmakers are flying high right now.
Nasdaq Bear Market: 5 Fantastic Growth Stocks You'll Regret Not Buying On the Dip
05:06am, Saturday, 06'th Aug 2022
These transformative growth stocks are begging to be bought following a 34% peak decline in the Nasdaq.
Exelixis Needs To Move Away From Its Overdependence On Cabozantinib
06:46am, Wednesday, 03'rd Aug 2022
Cabo is a blockbuster drug, but there are potential headwinds. EXEL needs to find other assets and move them to late stages.
Exelixis (EXEL) to Post Q2 Earnings: What is in the Cards?
01:55pm, Monday, 01'st Aug 2022
Investors will likely focus on the demand for Cabometyx and pipeline updates when Exelixis (EXEL) reports Q2 results. Operating expenses might have jumped.
3 Stocks That Are Fantastic Deals Right Now
05:55am, Thursday, 28'th Jul 2022
These supercharged growth stocks can make investors rich over the long haul.
2 Biotech Stocks to Help Recession-Proof Your Portfolio
10:45am, Friday, 22'nd Jul 2022
These companies' shares have outpaced the market and other biotech stocks this year.
1 Reason to Buy Exelixis Stock, and 1 Reason to Sell
10:15am, Friday, 22'nd Jul 2022
Some say Exelixis is a one-trick pony -- but it is a pretty good trick.
Exelixis (EXEL) Cabometyx Combo Study Meets Primary Goal
01:06pm, Tuesday, 12'th Jul 2022
Exelixis'(EXEL) late-stage study evaluating the combination of Cabometyx and Opdivo and Yervoy demonstrates significant improvement in progression-free survival at the primary analysis.
7 Best Biotech Stocks to Buy in July 2022
07:35am, Friday, 08'th Jul 2022
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict. The post 7 Best Biotech Stocks to Buy in July 2022 appeared
